000 | 01034 a2200313 4500 | ||
---|---|---|---|
005 | 20250516055733.0 | ||
264 | 0 | _c20111104 | |
008 | 201111s 0 0 fre d | ||
022 | _a1660-9379 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChambaz, I Chatton | |
245 | 0 | 0 |
_a[Primary hyperaldosteronism]. _h[electronic resource] |
260 |
_bRevue medicale suisse _cSep 2011 |
||
300 |
_a1736-8, 1740-2 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdenoma _xmetabolism |
650 | 0 | 4 |
_aAdrenal Cortex Neoplasms _xmetabolism |
650 | 0 | 4 | _aAdrenalectomy |
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperaldosteronism _xdiagnosis |
650 | 0 | 4 |
_aHypertension _xetiology |
650 | 0 | 4 |
_aHypokalemia _xetiology |
650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aSpironolactone _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aPechère-Bertschi, A | |
773 | 0 |
_tRevue medicale suisse _gvol. 7 _gno. 308 _gp. 1736-8, 1740-2 |
|
999 |
_c21191846 _d21191846 |